Form 4: Neogenomics Director David Brian Perez Reports Stock Transactions
SEC Form 4
Director David Brian Perez reports the release of restricted stock units and subsequent ownership of common stock in Neogenomics Inc.
Summary
- On August 10, 2024, David Brian Perez, a director of Neogenomics Inc., reported a transaction involving the release of 11,336 restricted stock units.
- These units converted into common stock, increasing Perez's direct ownership to 21,636 shares.
- The transaction was executed pursuant to the satisfaction of restricted stock units.
- Perez also holds various stock options with different exercise prices and expiration dates, as well as additional restricted stock units.
Sentiment
Score: 5
Explanation: This is a neutral filing, simply reporting a routine transaction. It doesn't inherently indicate positive or negative sentiment.
Positives
- The director's continued holding of stock options and restricted stock units may indicate confidence in the company's future performance.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. These filings are closely watched by investors seeking insights into management's perspective on the company's stock.
Stakeholder Impact
- The transaction has a minimal direct impact on stakeholders, as it primarily reflects internal compensation adjustments.
Key Dates
| Date | Description |
|---|---|
| 06/10/2023 | Date of exercisable stock options. |
| 06/10/2029 | Expiration date of stock options with an exercise price of $7.34. |
| 08/10/2024 | Date of transaction involving restricted stock units and common stock. |
| 08/10/2033 | Expiration date of stock options with an exercise price of $14.82. |
| 06/01/2025 | Date of exercisable stock options and restricted stock units. |
| 06/01/2034 | Expiration date of stock options with an exercise price of $13.71. |
| 08/13/2024 | Date of signature by Attorney-in-Fact. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.